Re: Protocol for Clozapine Rechallenge in a Case of Clozapine-induced Myocarditis. 2021

Marlon Danilewitz, and Reza Rafizadeh
25487Ontario Shores for Mental Health Sciences, Whitby, Ontario, Canada.

UI MeSH Term Description Entries
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

Marlon Danilewitz, and Reza Rafizadeh
July 2020, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
Marlon Danilewitz, and Reza Rafizadeh
April 2001, The Australian and New Zealand journal of psychiatry,
Marlon Danilewitz, and Reza Rafizadeh
January 2009, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists,
Marlon Danilewitz, and Reza Rafizadeh
January 2015, Psychosomatics,
Marlon Danilewitz, and Reza Rafizadeh
November 2023, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent,
Marlon Danilewitz, and Reza Rafizadeh
August 2011, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists,
Marlon Danilewitz, and Reza Rafizadeh
January 2011, The Australian and New Zealand journal of psychiatry,
Marlon Danilewitz, and Reza Rafizadeh
May 2022, BMJ case reports,
Copied contents to your clipboard!